Metabolic and toxicological considerations of newly approved prostate cancer drugs

Author： Tsao Che-Kai   Liaw Bobby   Yee Tiffany   Galsky Matthew D   Oh William K  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.7, 2013-07, pp. : 835-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

By Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 403-421

Informa Healthcare

Access to resources Recommend Favorite

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

By Rangel Erika B  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1531-1548

Informa Healthcare

Access to resources Recommend Favorite

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

By Moody David E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 675-697

Informa Healthcare

Access to resources Recommend Favorite

Toxicological considerations for intravitreal drugs

By Penha Fernando M   Rodrigues Eduardo B   Furlani Bruno A   Dib Eduardo   Melo Gustavo B   Farah Michel E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 8, 2011-08 ,pp. : 1021-1034

Informa Healthcare

Access to resources Recommend Favorite

Improving the safety of newly approved drugs

By  

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite